Elevated levels of IL-17A have been detected in patients with autoimmune gastritis, gastrointestinal metaplasia, and atypical hyperplasia, indicating that a protracted Th17 response may occur before the development of gastric cancer (39, 40). Here, IL17A is linked to autoimmune gastritis.